Abstract:Cancer remains a significant global public health concern, with increasing incidence and mortality rates worldwide. Oxidative stress, characterized by the production of reactive oxygen species (ROS) within cells, plays a critical role in the development of cancer by affecting genomic stability and signaling pathways within the cellular microenvironment. Elevated levels of ROS disrupt cellular homeostasis and contribute to the loss of normal cellular functions, which are associated with the initiation and progression of various types of cancer. In this review, we have focused on elucidating the downstream signaling pathways that are influenced by oxidative stress and contribute to carcinogenesis. These pathways include p53, Keap1-NRF2, RB1, p21, APC, tumor suppressor genes, and cell type transitions. Dysregulation of these pathways can lead to uncontrolled cell growth, impaired DNA repair mechanisms, and evasion of cell death, all of which are hallmark features of cancer development. Therapeutic strategies aimed at targeting oxidative stress have emerged as a critical area of investigation for molecular biologists. The objective is to limit the response time of various types of cancer, including liver, breast, prostate, ovarian, and lung cancers. By modulating the redox balance and restoring cellular homeostasis, it may be possible to mitigate the damaging effects of oxidative stress and enhance the efficacy of cancer treatments. The development of targeted therapies and interventions that specifically address the impact of oxidative stress on cancer initiation and progression holds great promise in improving patient outcomes. These approaches may include antioxidant-based treatments, redox-modulating agents, and interventions that restore normal cellular function and signaling pathways affected by oxidative stress. In summary, understanding the role of oxidative stress in carcinogenesis and targeting this process through therapeutic interventions are of utmost importance in combating various types of cancer. Further research is needed to unravel the complex mechanisms underlying oxidative stress-related pathways and to develop effective strategies that can be translated into clinical applications for the management and treatment of cancer.

Recent Advances in Cellular Signaling Interplay between Redox Metabolism and Autophagy Modulation in Cancer: An Overview of Molecular Mechanisms and Therapeutic Interventions

Redox balance and autophagy regulation in cancer progression and their therapeutic perspective

Redox Signaling: Potential Arbitrator of Autophagy and Apoptosis in Therapeutic Response

Redox Regulation of Autophagy in Cancer: Mechanism, Prevention and Therapy

Reactive Oxygen Species Regulation of Autophagy in Cancer: Implications for Cancer Treatment.

Cellular metabolic and autophagic pathways: traffic control by redox signaling

Autophagy, Oxidative Stress and Cancer Development

Oxidative Stress in Cancer Cell Metabolism

Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy

Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy

Molecular mechanisms of interplay between autophagy and metabolism in cancer

Targeting Metabolic-Redox Circuits for Cancer Therapy

Interplay of oxidative stress, cellular communication and signaling pathways in cancer

[A Review of the Redox Regulation of Tumor Metabolism].

An Update on Phytochemicals in Redox Homeostasis: “Virtuous or Evil” in Cancer Chemoprevention?

Autophagy, Metabolism, and Cancer

A paradoxical role of reactive oxygen species in cancer signaling pathway: Physiology and pathology

The Emerging Role of Oxidative Stress in Regulating Autophagy: Applications of Cancer Therapy.

Mitochondrial Redox Signaling And Tumor Progression

Reactive Oxygen Species as a Link between Antioxidant Pathways and Autophagy

Antioxidants activities of phytochemicals perspective modulation of autophagy and apoptosis to treating cancer